Can Telemedicine Improve Physical Distress for Rural Survivors of Head and Neck Cancer?
Pembrolizumab Plus Cetuximab in Resistant Head/Neck Squamous Cell Carcinoma
Head/Neck Cancers Symposium 2020: Psychosocial Screening May Reduce Distress in Patients With Head & Neck Cancer
Head/Neck Cancers Symposium 2020: Concurrent Chemoradiotherapy Plus Bevacizumab
Is Radiotherapy Feasible for Elderly Patients With Squamous Cell Head/Neck Cancer?
HPV DNA Blood Test for HPV-Associated Oropharyngeal Cancer Recurrence
Neuron Reprogramming and Status of p53 in Head and Neck Cancer
Plant-Based Drug May Benefit Patients With Oral Cancers
Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
Predicting Outcomes for Head & Neck Surgery in Elderly Patients
Changing Treatment Landscape of Metastatic Head and Neck Squamous Cell Carcinoma With Anti–PD-1/PD-L1 Agents
Clinical Updates: Head and Neck Cancers
University Hospitals Seidman Cancer Center
University of Alabama at Birmingham Comprehensive Cancer Center
University of Michigan Comprehensive Cancer Center
MD Anderson Cancer Center
Cetuximab (Head and Neck Cancers)
American Head & Neck Society (AHNS)
NCCN Guidelines for Patients®: Thyroid Cancer
ThyCa: Thyroid Cancer Survivors’ Association, Inc.